샘플 요청 목록

 카트 문의
시장보고서
상품코드
1780710

세계의 혈액 뇌 장벽을 통한 약물전달 시장

Drug Delivery Across Blood Brain Barriers
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 297 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 혈액 뇌 장벽을 통한 약물전달 시장은 2030년까지 46억 달러에 도달

2024년에 37억 달러로 추정되는 세계의 혈액 뇌 장벽을 통한 약물전달 시장은 2024-2030년에 CAGR 3.7%로 성장하며, 2030년에는 46억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 트로이 목마 어프로치는 CAGR 3.9%를 기록하며, 분석 기간 종료까지 20억 달러에 달할 것으로 예상됩니다. 이중특이성항체 RMT 어프로치 분야의 성장률은 분석 기간 중 CAGR 3.1%로 추정됩니다.

미국 시장은 10억 달러로 추정, 중국은 CAGR 6.8%로 성장 예측

미국의 혈액 뇌 장벽을 통한 약물전달 시장은 2024년에 10억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR 6.8%를 뒤쫓아 2030년까지 9억 2,460만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.5%와 2.8%로 예측됩니다. 유럽에서는 독일이 CAGR 2.1%로 성장할 것으로 예측됩니다.

세계의 ' 혈액 뇌 장벽을 통한 약물전달 ' 시장 - 주요 동향과 촉진요인 정리

혈액뇌관문 통과가 왜 어려운가?

혈액 뇌 장벽(BBB)은 대부분의 약물이 뇌에 도달하는 것을 방해하므로 신경질환 치료에 있으며, 가장 큰 장애물 중 하나입니다. 이 보호 메커니즘은 독소로부터 뇌를 보호하는 데 중요하지만, 잠재적인 신경 치료제의 98% 이상을 차단하므로 알츠하이머병, 파킨슨병, 뇌종양, 간질과 같은 질병을 치료하기가 매우 어렵습니다. 기존의 약물전달 방식으로는 BBB를 효과적으로 통과할 수 없기 때문에 비침습적이고 표적화된 첨단 전달 시스템 개발이 필요하게 되었습니다.

어떤 기술 혁신이 돌파구를 마련할 수 있는가?

최근 나노테크놀러지, 초음파를 통한 전달, 수용체 표적 운송 메커니즘의 발전은 BBB를 통과하는 약물전달에 혁명을 불러일으키고 있습니다. 지질 기반 나노입자, 엑소좀 기반 캐리어, 펩티드 매개 약물 운송 시스템은 뇌 조직에 표적 치료 전달을 가능하게 합니다. 집속 초음파 기술(FUS)은 BBB를 일시적으로 파괴하여 약물이 뇌의 특정 부위에 도달할 수 있도록 합니다. 또한 비강 약물전달, 유전자 치료 벡터, 줄기세포 기반 약물 운반체는 BBB 투과성을 우회하거나 조절할 수 있는 능력으로 인기를 끌고 있습니다.

투자와 확장을 촉진하는 시장 동향은?

신경질환은 전 세계에서 증가 추세에 있으며, 제약사 및 생명공학 기업은 BBB를 통과하는 치료제에 대한 투자를 강화하고 있습니다. 정부 기관, 특히 미국 국립보건원(NIH)과 유럽연구위원회는 새로운 BBB 전달 기술 연구에 자금을 지원하고 있습니다. 개별화된 신경학적 치료의 추진도 BBB 투과성 제제의 채택을 가속화하고 있습니다.

시장 성장의 주요 촉진요인은?

혈액뇌관문 통과 약물전달 시장의 성장은 신경 퇴행성 질환에 대한 효과적인 치료법에 대한 수요 증가, 나노 의료의 발전, 뇌 표적 약물 치료에 대한 연구개발 자금 증가에 의해 이루어질 것입니다. 또한 BBB 침투를 위한 바이오테크놀러지와의 제휴 확대와 AI를 활용한 신약개발도 기술 혁신에 박차를 가하고 있습니다. 또한 비침습적 약물전달법과 생체 모방형 약물 운반체의 등장으로 신경질환 치료의 가능성이 재구성되고 있습니다.

부문

약물전달 기술(트로이 목마 어프로치, 이중특이성항체 RMT 어프로치, BBB 투과성 향상, 수동 확산, 기타 비침습적 BBB 기술), 애플리케이션(알츠하이머병, 간질, 파킨슨병, 다발성 경화증, 헌터 증후군, 뇌종양, 기타)

조사 대상 기업의 예

  • AbbVie Inc.
  • Aliada Therapeutics
  • Angiochem Inc.
  • ArmaGen Technologies, Inc.
  • Arrakis Therapeutics
  • BioArctic AB
  • Bioasis Technologies Inc.
  • BiOasis Technologies, Inc.
  • Bristol-Myers Squibb Company
  • CarThera
  • Cordance Medical Inc.
  • Denali Therapeutics Inc.
  • Eascra Biotech
  • F. Hoffmann-La Roche Ltd
  • Gate2Brain
  • Genentech, Inc.
  • Herantis Pharma Plc
  • Insightec Ltd.
  • Lundbeck A/S
  • Nanomerics Ltd.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계 고유 SLM를 쿼리 하는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.07

Global Drug Delivery Across Blood Brain Barriers Market to Reach US$4.6 Billion by 2030

The global market for Drug Delivery Across Blood Brain Barriers estimated at US$3.7 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Trojan Horse Approach, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Bispecific Antibody RMT Approach segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 6.8% CAGR

The Drug Delivery Across Blood Brain Barriers market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$924.6 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global "Drug Delivery Across Blood-Brain Barrier" Market - Key Trends & Drivers Summarized

Why Is Crossing the Blood-Brain Barrier So Challenging?

The blood-brain barrier (BBB) is one of the most significant obstacles in treating neurological disorders, as it prevents most drugs from reaching the brain. This protective mechanism, while crucial for shielding the brain from toxins, blocks over 98% of potential neurotherapeutics, making the treatment of diseases like Alzheimer’s, Parkinson’s, brain tumors, and epilepsy extremely difficult. Traditional drug delivery methods fail to penetrate the BBB effectively, necessitating the development of advanced non-invasive and targeted delivery systems.

Which Technological Innovations Are Enabling Breakthroughs?

Recent advancements in nanotechnology, ultrasound-mediated delivery, and receptor-targeted transport mechanisms are revolutionizing drug delivery across the BBB. Lipid-based nanoparticles, exosome-based carriers, and peptide-mediated drug transport systems allow for targeted therapeutic delivery to brain tissues. Focused ultrasound technology (FUS) temporarily disrupts the BBB, enabling drugs to reach specific brain regions. Additionally, intranasal drug delivery, gene therapy vectors, and stem cell-based drug carriers are gaining traction for their ability to bypass or modulate BBB permeability.

What Market Trends Are Driving Investment and Expansion?

With neurological disorders on the rise globally, pharmaceutical and biotech companies are ramping up their investments in BBB-crossing therapeutics. Government agencies, particularly the National Institutes of Health (NIH) and European Research Council, are funding research into novel BBB delivery techniques. The push for personalized neurology treatments is also accelerating the adoption of BBB-permeable drug formulations.

What Are the Major Growth Drivers in This Market?

The growth in the Drug Delivery Across Blood-Brain Barrier market is driven by increasing demand for effective treatments for neurodegenerative diseases, advancements in nanomedicine, and rising R&D funding for brain-targeted drug therapies. The expansion of biotech collaborations and AI-driven drug discovery for BBB penetration is also fueling innovation. Furthermore, the emergence of non-invasive delivery methods and biomimetic drug carriers is reshaping treatment possibilities for neurological disorders.

SCOPE OF STUDY:

The report analyzes the Drug Delivery Across Blood Brain Barriers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drug Delivery Technology (Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion, Other Non-Invasive BBB Technologies); Application (Alzheimer's Disease, Epilepsy, Parkinson's Disease, Multiple Sclerosis, Hunter's Syndrome, Brain Cancer, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AbbVie Inc.
  • Aliada Therapeutics
  • Angiochem Inc.
  • ArmaGen Technologies, Inc.
  • Arrakis Therapeutics
  • BioArctic AB
  • Bioasis Technologies Inc.
  • BiOasis Technologies, Inc.
  • Bristol-Myers Squibb Company
  • CarThera
  • Cordance Medical Inc.
  • Denali Therapeutics Inc.
  • Eascra Biotech
  • F. Hoffmann-La Roche Ltd
  • Gate2Brain
  • Genentech, Inc.
  • Herantis Pharma Plc
  • Insightec Ltd.
  • Lundbeck A/S
  • Nanomerics Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Drug Delivery Across Blood Brain Barriers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Burden of Neurological Disorders Accelerates Demand for Blood-Brain Barrier Drug Delivery Technologies
    • Advances in Nanotechnology and Carrier Systems Strengthen the Business Case for Targeted CNS Therapies
    • Limitations of Conventional Therapies Throw the Spotlight on Non-Invasive BBB Penetration Techniques
    • Expansion of Neuro-Oncology Drug Pipelines Spurs Innovation in Brain-Targeted Delivery Methods
    • Increased R&D in Focused Ultrasound and Magnetic Field-Assisted Delivery Drives Adoption
    • Favorable Funding Landscape Propels Growth of BBB-Crossing Drug Platforms
    • Rising Demand for Personalized Neurological Treatments Expands Market Opportunities for Smart Delivery Systems
    • Regulatory Incentives for Orphan Neurological Drugs Support Commercialization of BBB-Enabled Therapies
    • Collaborations Between Academia and Industry Generate Momentum in Translational Delivery Research
    • Challenges in Systemic Toxicity Create Opportunities for Precision BBB Drug Targeting
    • Emerging Role of Exosomes and Vesicle-Based Delivery Systems Drives Innovation in CNS Drug Development
    • Shift Toward Early Diagnosis and Intervention Models Spurs Need for Fast-Acting BBB-Penetrating Drugs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug Delivery Across Blood Brain Barriers Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug Delivery Across Blood Brain Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Trojan Horse Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Trojan Horse Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Trojan Horse Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Bispecific Antibody RMT Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Bispecific Antibody RMT Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Bispecific Antibody RMT Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Increasing the Permeability of BBB by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Increasing the Permeability of BBB by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Increasing the Permeability of BBB by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Passive Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Passive Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Passive Diffusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Non-Invasive BBB Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Non-Invasive BBB Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Non-Invasive BBB Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hunter's Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hunter's Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hunter's Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Brain Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Brain Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Brain Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Alzheimer's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Alzheimer's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Alzheimer's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • JAPAN
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • CHINA
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • EUROPE
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Drug Delivery Across Blood Brain Barriers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • FRANCE
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • GERMANY
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: UK 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Spain 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Spain 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Russia 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Russia 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Drug Delivery Across Blood Brain Barriers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Australia 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Australia 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • INDIA
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: India 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: India 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: South Korea 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: South Korea 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Drug Delivery Across Blood Brain Barriers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Argentina 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Argentina 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Brazil 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Brazil 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Mexico 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Mexico 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Drug Delivery Across Blood Brain Barriers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Iran 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Iran 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Israel 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Israel 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: UAE 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: UAE 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030
  • AFRICA
    • Drug Delivery Across Blood Brain Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Africa 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Drug Delivery Technology - Percentage Breakdown of Value Sales for Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion and Other Non-Invasive BBB Technologies for the Years 2015, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Drug Delivery Across Blood Brain Barriers by Application - Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Africa 15-Year Perspective for Drug Delivery Across Blood Brain Barriers by Application - Percentage Breakdown of Value Sales for Hunter's Syndrome, Brain Cancer, Others, Alzheimer's Disease, Epilepsy, Parkinson's Disease and Multiple Sclerosis for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제